Vanguard Global Advisers »

Matinas Biopharma Hldgs shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Matinas Biopharma Hldgs (MTNB) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Matinas Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Matinas Biopharma Hldgs held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Matinas Biopharma Hldgs by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $669 1.3k 0.50

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Matinas Biopharma Hldgs

Geode Capital Management
Vanguard Group
Citadel Advisors
BlackRock
Vanguard Capital Management
Holos Integrated Wealth
Renaissance Technologies
Susquehanna International
Vanguard Fiduciary Trust
XTX Topco
Virtu Financial
State Street Corporation
Sargent Investment Group
Tower Research Capital
Vanguard Global Advisers

View all funds holding Matinas Biopharma Hldgs